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Abstract
This article explores factors that impede the implementation of advance directives to 
refuse treatment (ADs) in three European countries: England, Germany and France. 
Taking into account socio-cultural and legal aspects, the article shows the extent, to 
which the law can, and does, influence physicians’ decisions to implement ADs. The 
findings presented are based on qualitative interviews exploring physicians’ sense of 
duty to respect ADs and the reasons given for failing to implement the law. It will be 
argued that this depends on: 1) how strictly the legal status of ADs is defined, and 
2) whether the law actually addresses the reasons why physicians may hesitate to 
implement ADs (e.g. uncertainty about validity, importance of patient preferences). 
The article emphasises the importance of doctor-patient communication and shows 
how the implementation of ADs could be improved by making discussions about treat-
ment preferences a legal requirement.
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1 Introduction
In the last decade, many western European countries have adopted legislation 
on advance decisions to refuse treatment (ADs).1 And yet, despite the shared 
appreciation of ADs, each country accords a different legal status to these 
directives.
Whereas countries with a strong emphasis on patient autonomy, such as 
England and Germany, have recognised the binding force of advance direc-
tives for many years, countries that are less concerned with patient autonomy, 
such as France, struggled to accord binding legal value to ADs.2 These differ-
ences reflect the different values that are dominant in each country, and the 
different socio-political contexts.3 England, for example, is a country with a 
strong liberal tradition supporting individual rights. This tradition goes back to 
the Magna Carta in 1215, and philosophers such as Locke4 and Mill5 who influ-
enced England’s political and legal system. In such an environment, respect 
for patient autonomy is a fundamental value and ADs are seen as important 
tools to extend patient autonomy. Similarly, Germany is a country with a 
strong focus on respect for patient wishes. Since the Nuremberg trials in 1946, 
physicians in Germany aimed to re-establish trust into medical interventions 
by basing decisions on patients’ wishes. In light of the crimes committed by 
the Nazi doctors, euthanasia could not be discussed as a means to guarantee 
autonomy at the end of life, as was the case in many other Western countries, 
and the German debate focused early on ADs.
Since the 1980s, there has been an extensive public debate raising awareness 
about ADs and about each citizen’s responsibility to think about their treat-
ment preferences in the event of incapacity.6 In contrast to this, the French 
1   R. Andorno, N. Biller-Andorno and S Brauer, ‘Advance health care directives: towards a coor-
dinated European policy?’, European Journal of Health Law 16(3) (2009) 207-227; N. Biller-
Andorno, S. Brauer and P. Lack (eds.), Advance Directives: Ethical Issues from an International 
Perspective (Dordrecht: Springer, 2014).
2   D. Veshi and G. Neitzke, ‘Advance Directives in Some Western European Countries: A Legal 
and Ethical Comparison between Spain, France, England, and Germany’, European Journal of 
Health Law 22(4) (2015) 321-345.
3   R. Horn, ‘Advance directives in England and France: Different Concepts, Different Values, 
Different Societies’, Health Care Analysis 22(1) (2012) 59-72.
4   J. Locke, The Two Treatises of Government (London: Everyman, 1993) [Original work published 
1690].
5   J.S. Mill, On Liberty (New York: Cosimo Classics, 2005) [original work published 1859].
6   R. Horn, ‘Euthanasia and end-of-life practices in France and Germany. A comparative study’, 
Medicine, Healthcare and Philosophy 16(2) (2011) 197-209.
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healthcare shifted only recently towards a more patient-centred approach. For 
a long time, France has defended a physician-centred approach focusing on 
physicians’ responsibilities to guarantee that individual choices are in accord 
with socially accepted values. Patients were seen as vulnerable persons that 
ought to be protected by physicians who represent societal values, and, there-
fore, are legitimised to make decisions on behalf of the patient. This under-
standing of the individual as embedded within society refers to Rousseau’s 
social contract and the continuing influence of Catholic values in secular 
France.7 Although today patient preferences are seen as increasingly impor-
tant, it has taken a long time for ADs to become legally binding.
Despite these socio-cultural differences, there are some similarities between 
the three countries in terms of the implementation of ADs. In none of the 
aforementioned countries are ADs always implemented in practice, nor do 
doctors always respect them. Each country’s legislation leaves scope for inter-
pretation and ADs can easily be invalidated8 or ignored without consequences 
for the physician. As White and Willmott9 have shown, it is not law itself that 
motivates physicians to respect ADs, but rather that doctors’ compliance with 
law in this respect reflects whether their reasoning (e.g. respect for patient 
preferences) is in line with the law.10 By comparing the views of physicians 
from these different countries, the present article explores and shows however 
the extent, to which the law can, and does, influence physicians’ decisions. It 
will be argued that this depends on: 1) how strictly the legal status of ADs is 
defined, and 2) whether the law actually addresses the reasons why physicians 
may hesitate to implement ADs (e.g. uncertainty about validity, importance of 
patient preferences).
The findings presented below are based on qualitative interviews with phy-
sicians in England, Germany and France. The interviews explored physicians’ 
sense of duty to respect ADs and the reasons given for failing to implement the 
law. My analysis focusses on the role the law plays for physicians and considers 
the respective cultural, legal, and social context of each country. This compara-
tive approach allows me to identify general, as well as country specific, factors 
7    Ibid.; R. Horn, Le droit de mourir: Choisir sa fin de vie en France et en Allemagne (Rennes: 
Presses Universitaires de Rennes, 2013).
8    S. Michalowski, ‘Advance refusals of life-sustaining medical treatment: The relativity of 
an absolute right’, The Modern Law Review 68 (2005) 958-982.
9    B. White, L. Willmott, M. Parker, C. Cartwright and G. Williams, ‘What do emergency phy-
sicians think of law?’, Emergency Medicine Australasia 24(4) (2012) 355-356.
10   B. White and L. Willmott, ‘Are doctors who know the law more likely to follow it?’, Journal 
of Medical Ethics Blog, 17 August 2016.
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that impede the implementation of ADs. The article emphasises the impor-
tance of doctor-patient communication and shows how the implementation 
of ADs could be improved by making discussions about treatment preferences 
a legal requirement.
2 Methods
Based on 30 semi-structured face-to-face interviews, this article explores phy-
sicians’ perspectives on their duties to respect ADs, and their general attitudes 
towards these documents. In 2014, 8 English, 13 German and 9 French phy-
sicians were recruited from university hospitals (n=2 in England (within one 
Trust), n=3 in Germany, n=2 in France). The focus was on doctors working in 
services which take care of seriously or terminally ill patients such as, oncol-
ogy, neurology (neuro-oncology, amyotrophic lateral sclerosis), and palliative 
care. This study builds on a previous study on this topic for which interviews 
were carried out in 2011 in England and France.11 No interviews on the spe-
cific topic of ADs were conducted in Germany at that earlier time. This is why 
more physicians were interviewed in Germany in 2014 than in England and 
France. Each interview lasted approximately 45 minutes, was audio recorded 
and transcribed.
The interviews covered a range of different topics related to physicians’ 
experiences with ADs and, more broadly, with communication and decisions 
at the end of life. For the purpose of this article, I focused on data reflecting 
physicians’ views on benefits and challenges of ADs and their sense of duty 
to comply with and apply the law. The interview data is supported by ethno-
graphic observations carried out in each country during 2014-15 over a period 
of three to four months.
The analysis of data involved numerous readings of the transcribed inter-
views and field notes. This was followed by identifying and refining compara-
ble recurrent themes and patterns that came out during the interviews, which 
describe the physicians’ attitudes. Ethical approval for the study was obtained 
in all three countries from the respective authorities.
Participants are identified according to their nationality (EDn; GerDn; FDn). 
Gender or medical speciality did not come up as a factor influencing doctors’ 
11   R. Horn, ‘ “I don’t need my patients’ opinion to withdraw treatment”: Patient preferences 
at the end-of-life and physician attitudes towards advance directives in England and 
France’, Medicine, Healthcare and Philosophy 17(3) (2014) 425-435.
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compliance with the law; therefore, in order to maximise anonymity, age and 
gender are not reported here.
3 Results
3.1 England
3.1.1 The Legal Context
Respect for patient autonomy is a dominant principle in English (and Welsh) 
law,12 and can outweigh medical decisions. In 1984, it was stated that patients 
can “reject [medical] advice for reasons which are rational, or irrational, or for 
no reason”.13 Following this trend, ADs have been legally binding under com-
mon law since the 1990s,14 and since the Mental Capacity Act (MCA) 2005 came 
into force in 2007,15 ADs also have binding force under statutory law. According 
to the law, an AD is legally binding if it was issued voluntarily by a competent 
and sufficiently informed patient, and applies to the circumstances that have 
arisen. In the case where an AD concerns the withdrawal of life-sustaining 
treatment, the MCA additionally requires that the directive must be written, 
signed and witnessed, and it must clearly state that the decision is to apply 
even if life is at risk. In case of doubt or where the person has not anticipated 
their will, the Act is underpinned by the best interests standard. This standard 
requires that the physician or person with lasting power of attorney who make 
decisions on behalf of an incompetent person:
 •  must permit and encourage the latter to participate ‘so far as reason-
ably practicable’ in any decision regarding them;
 •  consider the person’s past and present wishes, feelings, beliefs, values 
and any other factor the person would consider if they were able to 
do so;
 •  and take into account the opinion of any other person who could con-
tribute to determining what would be in the person’s best interests.16
12   England and Wales have both adopted the Mental Capacity Act 2005 providing the legal 
framework for ADs. In the following, because my data was gathered in England, I will only 
refer to the ‘English’ situation.
13   Sidaway v. Board of Governors of the Bethlem Royal Hospital [1985] AC 871, 904-905.
14   Re C (adult: refusal of treatment) [1994] 1 WLR 290; Re AK (medical treatment: consent) 
[2001] 1 FLR 129; Re B (adult: refusal of medical treatment) [2002] 2 All ER 449.
15   Department of Health, Mental Capacity Act (London: HMSO, 2005). 
16   Ibid., section 4.
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In case the decision concerns the withdrawal of artificially assisted nutrition 
and hydration for patients in persistent vegetative state and no written AD 
exists, this decision has to be approved by the court.17
3.1.2 English Physicians’ Views: “I Worry More About Having the 
Conversation than Having the Written Document”
The MCA lists many conditions to be fulfilled for an AD to be valid. These pre-
cautionary measures seem to be reflected in English physicians’ attitudes. In 
compliance with the law, the physicians interviewed in this study confirmed 
that ADs are very important documents helping them to make decisions for 
incompetent patients. While physicians considered ADs legally binding, they 
expressed reservations about the written document and its ability to express 
a patient’s wish regarding a concrete situation. Rather than taking ADs as 
the ultimate documentation of a patient’s wish, English physicians consid-
ered them a “very useful tool [. . .] to talk and know what a person wishes to 
do” (ED7).
It’s a way of, at least, having the conversation or starting it, otherwise 
people might not find it that easy. It’s this piece of paper but, you know, 
it’s used as an opportunity to think about some things . . . I think it gives 
permission to everybody to talk about difficult things which one would 
talk about anyway, but it does ease it. (ED8)
I am ambivalent about actually the value in terms of the written docu-
ment. [. . .] I worry more about having the conversation than having the 
written document. (ED1)
Discussing end-of-life preferences and continuity of the relationship with the 
patient were considered as “more useful than a piece of paper” (ED7). One 
of the physicians interviewed told me that staff does not need written ADs 
because;
17   As Kitzinger and Kitzinger show, this measure can lead to important delays in the deci-
sion-making which is often not in the best interest of the patient. This article will how-
ever not focus on the particular case of patients in persistent vegetative state. J. Kitzinger 
and C. Kitzinger, ‘Causes and consequences of delays in treatment-withdrawal from PVS 
patients: A case study of Cumbria NHS Clinical Commissioning Group v Miss S and Ors’, 
Journal of Medical Ethics (online first) (2016).
Heruntergeladen von Brill.com06/10/2021 09:04:07AM
via Universitat Augsburg
529“Why Should I Question a Patient’s Wish?”
european Journal of health law 24 (2017) 523-540
We would always write down their [patients] wishes in the notes and 
clearly follow their wishes. So if we have a patient who says I absolutely 
want to go home to die, even if in normal circumstances they would 
be too ill to travel, we would do everything we can to get that patient 
to the right destination for their death. [. . .] So, if we clearly have got 
wishes we will put those into action. I think we write them down on the 
notes. (ED4)
Indeed, during my observations, I saw that English doctors would write down 
the conversation they had with the patient. One copy was put in the patient 
file and one copy was sent to the patient for their own records.
Physicians also suggested that building a relationship where the patient can 
“trust [the doctor] to make a sensible decision on their behalf” (ED2) can be 
more important than filling in a form. One of the physicians explained the 
importance of a good doctor-patient relationship:
What the vast majority of people want is to know that they are going to 
be cared for, in the right way. [. . .] what they really want is that we, us 
doctors or a team, will consider your best interests and do what’s right for 
you, knowing you as we do. And then they sort of think, yes, that’s what 
I want. That’s what they really want. And that’s ok because they know us 
and they know that we are a team who cares about them and that we are 
going to do the right thing. (ED8)
In order to build mutual trust and establish what patients want, English physi-
cians commented that open communication about diagnosis and prognoses 
are very important. The physicians I observed during this study, demonstrated 
their openness when communicating diagnoses to their patients. And even 
where patients wanted to know their prognosis, the doctors did not hesitate to 
explain the statistics. In response to my question about whether they wor-
ried that patients might misunderstand a given prognosis, one of the doctors 
replied: “Patients are not stupid, if you explain things well, they understand. 
They can find the statistics in the internet but I prefer they ask me, so that I can 
explain the numbers.” (ED4)
Although English physicians value respect for patient preferences, they 
hesitate to encourage their patients to write an AD, partly because they are 
concerned that ADs may not always represent a patient’s wish regarding a spe-
cific situation. This concern echoes the legal framework of ADs, which define 
the conditions under which these documents are valid or not. What counts 
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for English physicians, when it comes to knowing or discerning their patients’ 
treatment preferences, is communication. However, while, most physicians 
in this study considered that ADs can be useful tools to generate discussion 
about treatment preferences with the patient, another study has shown that 
this does not always work in practice.18 This is partly because physicians lack 
specific training for discussing ADs and the public awareness of ADs is still low.19 
As we will see in the next section, the situation in Germany is in many aspects 
similar to that in England, yet with a clearer legal statement and broader pub-
lic awareness.
3.2 Germany
3.2.1 The Legal Context
Like English law, German law has been emphasising respect for the patients’ 
wishes for many years.20 Since the 1990s, in numerous cases regarding treat-
ment withdrawal decisions for incompetent patients, the court’s decisions were 
based on the previous or presumed patient wishes.21 A law, passed in 2009,22 
recognised the binding force of ADs also under statutory law. This law specifies 
the doctors’ obligations to respect ADs regardless of whether the patient has a 
terminal illness or not. In order to be valid, the AD has to be concrete and take 
into account specific situations.23 In case of ambiguity or absence of a written 
AD, the physician, together with the surrogate, has to establish the presumed 
wish of the patient based on previous statements and general values.24 Unlike 
in English Law where court approval has to be sought in case of withdrawal 
of life sustaining treatment in the absence of a clear AD, German law requires 
such approval only in case of conflict between the physician and the surrogate 
or family. Failure to respect a valid AD violates the patient’s right to physical 
integrity25 and can be punished under paragraph 223 of the criminal law.
18   Supra note 11.
19   J. Kitzinger and C. Kitzinger, Increasing Understanding and Uptake of Advance Decisions in 
Wales (Public Policy Institute for Wales, 2016), online at http://ppiw.org.uk/files/2016/02/
PPIW-Report-Increasing-the-awareness-and-uptake-of-Advance-Decisions.pdf.
20   Supra note 6.
21   BGH. 1StR 357/94. 13.9.1994; OLG Frankfurt a.M. 20 W 224/98. 5.8.1998; BGH. XII ZB 2/03. 
17.03.2003.
22   Drittes Gesetz zur Änderung des Betreuungsrechts vom 29.07.2009. BGBI. I: 2286.
23   BGH. XII ZB 61/16. 06.07.2016.
24   U. Wiesing, R.J. Jox, H.J. Heßler and G.D. Borasio, ‘A new law on advance directives in 
Germany’, Journal of Medical Ethics 36 (2010) 779-783.
25   BGH 4 StR 700/94; BGH 2 StR 454/09.
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3.2.2 German Physicians’ Views: “Always Challenging ADs Undermines 
the Whole Idea”
The German physicians interviewed confirmed, in line with the law, that ADs 
are completely binding for them and cannot be ignored.26 They considered 
ADs as very important tools that allow for the enactment of patients’ wishes, 
even when the patient has lost capacity. Unlike their English colleagues, 
the German doctors rarely challenged the validity of anticipated decisions. 
Currently in Germany, there are over 200 official AD-forms available.27 Most 
forms pre-define concrete situations and also include an empty page where 
patients can explain general beliefs and wishes in order to facilitate the inter-
pretation of the AD. Referring to this dual process (precise decisions and gen-
eral values), as well as to the law, German doctors believed that ADs are valid 
instruments to express treatment preferences and should not be questioned: 
“[. . .] the new law clearly states that the patient will has to be respected. [. . .] 
you need a very good reason not to implement the patient will” (GerP4).
During my observations and an informal discussion, one doctor explained: 
“Why should I question my patients’ wishes only because they were made 
in advance? They know what they want, and ADs are legally binding, so why 
should I question what they want?” (GerP2). Another physician explained:
I find it difficult when doctors say that they don’t know if an AD really 
applies to a concrete situation, it’s kind of paternalistic. If we think like 
this, ADs make no sense at all. I always explain to my patients that there 
is a risk that they may see things differently in a particular situation. But 
this is the patient’s decision. [. . .] Challenging every AD [. . .] undermines 
the whole idea of ADs. [. . .] I find it extremely dangerous to constantly 
question the validity of ADs and not taking them seriously. (GerP12)
Also another physician thought that ADs always entail some risks, specifically 
the “. . . risk of withdrawing treatment too early. That’s possible. Yet, it’s impor-
tant to carefully consider if this is really worse than suddenly being in a situa-
tion you never wanted to be in” (GerP7).
One doctor explained that there are some physicians who find it difficult 
to respect an AD that goes against their medical opinion. “In those cases, you 
really need to teach them [physicians] like in school: ‘Guys, you have to respect 
this. This is your job! It is your professional duty to respect this!’ ” (GerP2).
26   Supra note 6.
27   R.J. Jox, H.J. Heßler and G.D. Borasio, ‘Entscheidungen am Lebensende, Vorsorgevollmacht 
und Patientenverfügung’, Der Nervenarzt 79(6) (2008) 729-739.
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Like their English colleagues, German doctors explained that ADs should 
never be written without also having an in-depth discussion with the patient: 
“so that it’s clear what the patient wants” (GerP7). Indeed, a study by Lang-
Welzenbach et al.28 has shown that German physicians consider discussion 
about ADs as more valuable than a signed document.
Several physicians also mentioned potential conflicts with or between 
family-members and emphasised the importance of having end-of-life discus-
sions with all parties so that everyone has a chance to hear and learn what the 
patient wants (GerP2; GerP4; GerP5; GerP7).
It’s important that the family is there when the patient writes their AD 
so that everyone knows what the patient wants, and we can refer to this 
later (GerP5).
Clearly, if I discuss those things with the patient, and I note and record 
this, I cannot be attacked (GerP7).
It was argued that discussing end-of-life decisions helps to validate ADs and 
aid decisions about unexpected situations that are not covered in a written 
document.
When you discuss those things with the patient, you get to know their 
thoughts and can understand their wishes much better. Also things you 
wouldn’t think of discussing can be sorted or misconceptions about what 
could happen can be clarified with the patient and the family (GerP9).
Despite a strong sense of duty to respect ADs, aided by the clarity of the new 
law and a wide media coverage, physicians said that they do not always ask 
patients if they have written an AD. Several physicians explained that they 
believe that the palliative care teams will hold such conversations (GerP11; 
GerP10; GerP2). Other physicians said that they prefer to wait until the patient 
starts the discussion.
Some people want to get it off their chest that they have an AD, some 
people find it very important. So some patients start talking and others 
don’t start talking but are relieved when we ask and they say, ‘yes, I’ve got 
one and it is very important for me. I’ve got it at home and will bring it 
28   M. Lang-Welzenbach, C. Roedel and J. Vollmann, ‘Advance directives in radiation oncol-
ogy: Attitudes of patients, physicians and nurses’, Ethik in der Medizin 20(4) (2008) 300-312.
Heruntergeladen von Brill.com06/10/2021 09:04:07AM
via Universitat Augsburg
533“Why Should I Question a Patient’s Wish?”
european Journal of health law 24 (2017) 523-540
next time’. We then make a copy and put it in the patient file. That’s how 
we do it (GerP8).
Also another physician confirmed that when he asks his patients whether they 
have written an AD, almost all patients say they did, and those who have not 
done it yet are thinking of doing so. “I think patients don’t always know when 
they should tell us, and we don’t know when we should ask” (GerP9).
Despite the strong sense of duty to comply with the law on ADs, the lack of 
communication not only leads to physicians not knowing if someone has writ-
ten an AD but also not knowing whether someone has thought about writing 
one. This becomes particularly important when considering recent statistics 
which show that 93% of the German population knows about ADs and 45% 
are planning to write one, but only 28% have actually written one.29 The sta-
tistics suggest that Germany is the country in Europe with the highest level of 
awareness of ADs. Among other reasons, this is due to the strong media cover-
age of ADs since the 1990s. As we will see in the next sections, in France, unlike 
in Germany, there is very little public awareness of ADs.
3.3 France
3.3.1 The Legal Context
In 2005, ADs were mentioned for the first time in France in a ‘law on patients’ 
rights and the end of life’.30 This law clearly stated that physicians have to 
respect a competent patient’s treatment refusal, even where the refusal con-
cerns clinically assisted hydration or nutrition. The law also stated that the 
‘patient can write an AD’ and the ‘physician can take them into account’ but 
is not obliged to respect them (L. 1111-11 Public Health Code). According to 
the law of 2005, decisions for incompetent patients should be made among 
medical colleagues (décision collégiale), meaning that the physician has to 
discuss such a decision with another doctor. The ‘collegial decision’ is a pro-
cedure required by the medical code of conduct in order to guarantee medi-
cally sound decisions and was introduced into the law of 2005.31 Prior to the 
29   Institut für Demoskopie Allensbach, Deutlicher Anstieg bei Patientenverfügungen, 
Allensbacher Kurzbericht 10.12.2014.
30   Loi n° 2005-370 du 22 avril 2005 relative aux droits des malades et à la fin de vie. Journal 
Officiel 95, 7089.
31   As Thouvenin points out, the law introduced herewith medical standards in order to 
regulate the doctor-patient relationship. [32] D. Thouvenin, ‘La loi n° 2005-370 du 22 avril 
2005, dite loi Leonetti: la médicalisation de la fin de vie’, in: J.L Ferry (ed.), Fin(s) de vie 
(Paris: PUF, 2011), pp. 303-368.
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collegial decision, the physician has to ‘consult’ a representative (personne de 
confiance), a relative or, where it exists, the AD of the concerned person with-
out those statements having obligatory value. The law of 2005 saw ADs as “indi-
cations” of wishes, but not as legally binding statements.32 Unlike in England 
and in Germany, there were no court decisions about treatment withdrawals 
for incompetent patients in France until the Lambert case in 2013.33 Following 
the huge media coverage around this and previous end-of-life cases (Chantal 
Sebire, Herve Pierra), a law on ‘new rights for patients and terminally ill per-
sons’ was voted in 2016.34 Amongst other things, this law now recognises the 
binding value of ADs. However, it also allows for the physician to question 
the ‘appropriateness and applicability of the ADs to the medical situation’, stat-
ing that in such instances the physician should make a décision collégiale. In 
other words, the law does not always require the physician to base the decision 
on the patient’s previous or presumed wishes and beliefs.
3.3.2 French Physicians’ Views: “If They Don’t Ask, They Don’t Want to 
Know or Make Decisions”
Treatment builds an essential part of the doctor-patient relationship in France, 
and physicians equate withdrawing treatment as a failure on a professional, as 
well as on a personal, level.35 Several French physicians interviewed confirmed 
how difficult it is for them to decide to withdraw treatment. As one of them 
explained:
It is difficult because our natural tendency is to treat. Telling someone 
who is competent that we stop treatment is a failure. It means that we 
have to accept a medical failure, and to break bad news. This is not grati-
fying. It is easier when the patient is not competent anymore because 
they don’t realise what we do (FD3).
32   B. Feuillet, ‘Les directives anticipées en France, un indice de consentement a effets lim-
ites’, in: S. Negri (ed.), Self-determination, Dignity and End-of-Life Care. Regulating Advance 
Directives in International and Comparative Perspective (Leiden: Martinus Nijhoff, 2011) 
pp. 195-207.
33   F. Begouin and L. Clavreul, ‘Dix questions autour de l’affaire Vincent Lambert’, Le Monde 
(29.1.2014).
34   Loi n° 2016-87 du 2 février 2016 créant de nouveaux droits en faveur des malades et des 
personnes en fin de vie, Journal Officiel 0028.
35   Supra notes 6 and 11.
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Rather than discussing patients’ preferences with regard to treatment with-
drawal, the physicians interviewed explained that they prefer not to tackle 
these issues unless the patient explicitly asks to discuss this.
If they don’t ask, I suppose they’re ok with my treatment. I don’t give 
treatment I don’t have any hope in, but if I have the slightest hope to 
improve the patient’s condition or to gain a little bit of time, I propose 
the treatment (FD5).
The definition of the ‘slightest hope’ largely varies among doctors and gives 
scope for interpretation. My observations suggested that French physicians do 
not hesitate to give treatment that has no effect, and in some cases even treat-
ment that is futile.36
Although French physicians agreed that they “have to tell the truth [. . .] and 
give the patient essential information such as that they won’t recover anymore” 
(FD9), they seemed to be fairly protective and aimed to reassure the patient 
rather than raise concerns about the future. Thus, as long as the patients do 
not ask questions, the doctors concluded that they do not want to know and 
explained that they do not want to ‘impose’ bad news on them (FD3; FD5; FD7). 
If “patients really want to know, they will get the information”, explained one 
of the doctors (FD1).
Not all French physicians agreed with this view, and one of the physicians 
interviewed explained that it is important for him to honestly answer patients’ 
questions. Yet, when he does so, he also wants to “reassure them [the patients] 
at the same time, explain that the question comes too early, and that we [staff] 
will do everything to ease the patient’s suffering”. (FD8) Several of the phy-
sicians interviewed said that they do not want to “frighten people” with bad 
news and possible future scenarios.
You know, I have been thinking a lot about this, and then I thought, ‘what 
gives me the right’, even if you know the statistics, and the prognostic is 
grim, even as a professional, ‘do I have the right to say ‘listen, in 1 or 2 years, 
you won’t be here anymore’? I don’t think I have the right to say that. [. . .] 
I am not in favour of brutal announcements [. . .] we are humans (FD2).
In an environment where physicians hesitate to confront patients with ‘bad 
news’ about prognoses, it is difficult to implement ADs which imply knowledge 
36   Supra note 6.
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of possible outcomes. As the interviews with the German physicians showed, 
patients need to be encouraged to discuss these issues with their consultant 
but rarely tackle these issues when they are not asked. Indeed, in 2014, when 
I did the interviews in France, physicians told me that they hardly see any writ-
ten ADs. Even though one of the wards I observed had started mentioning ADs 
and offering forms to complete and sign during the initial consultation, physi-
cians said that patients hardly ever return these documents (FD1; FD2; FD3).
One physician said that even if patients would return the signed docu-
ment, he is not certain that it should be respected because decisions should 
evolve “naturally” over time and cannot be made in advance (FD3). Another 
doctor explained that he is worried that ADs are only a “box ticking exercise” 
and thought that these decisions should be negotiated and discussed with the 
patient over time, and depending on the evolution of the illness. He admit-
ted that “ideally it would be important to discuss things with the patient”. Yet, 
because such discussions could be “malicious” for the patient, he thought that 
these decisions are better made among colleagues (FD9).
Although the law of 2005 did not recognise the binding force of ADs, several 
French physicians interviewed in 2014 mentioned that the law made it easier 
for them to speak about ADs with their patients (FD3; FD5; FD7). “In fact, the 
law made us talk to the patients. I think ADs are useful tools to initiate dis-
cussion about end-of-life decisions. [. . .] However, to be honest I didn’t have 
good experiences with it; patients didn’t react well to these discussions” (FD4). 
Another physician considered: “If there weren’t ADs there wouldn’t be any dis-
cussions. [. . .] If we didn’t have the law, nothing would move at all” (FD7).
Physicians referred to the potential force of the law and valued the idea of 
ADs at least as a means to facilitate discussion about difficult end-of-life deci-
sions. As we have seen, French physicians find it difficult to tackle end-of-life 
discussions and prefer to protect patients from bad news. Although the law of 
2005 did not immediately change well entrenched attitudes,37 my observations 
have shown that it had an impact on physicians’ perceptions of their duties 
to share information with patients. Since 2005, the discourse among physi-
cians became increasingly more critical towards medical decisions that do not 
respect patient wishes to refuse treatment.
37   Supra note 6; S. Pennec, A. Monnier, S. Pontone and R. Aubry, ‘End-of-life medical deci-
sions in France: A death certificate follow-up survey 5 years after the 2005 act of Parliament 
on patients’ rights and end of life’, BMC Palliative Care 11(25) (2012).
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4 Discussion
The interviews with physicians and the observations in England, Germany 
and France suggest a reciprocal influence between the legislation on ADs and 
physicians’ attitudes. If physicians do not always implement ADs, this does 
not simply refer to the lack of influence of the law.38 Other factors such as the 
wording, the rigidity and the appropriateness seem to play a role.
In England, a country with a strong liberal tradition, both law and physi-
cians value patient preferences. The emphasis on the patient’s authentic 
wishes raises concerns about the possibility to express valid wishes in advance. 
In order to avoid uncertainty about the validity of an anticipatory decision, 
English physicians emphasised the importance of good communication when 
the patient is competent. Yet, although they did not hesitate to give patients 
open information about their situation as required by law,39 they hesitated to 
discuss ADs. It is this lack of communication that is the reason for the weak 
implementation of written ADs in England. English physicians complied with 
legal requirements such as sharing information with patients or respecting 
ADs, but they did not always implement professional guidelines inviting them 
to discuss treatment preferences with the patient.40 The existing correlation 
between the law and physicians’ attitudes suggests that a legal framework 
focusing less on criteria that limit the validity of ADs and more on physicians’ 
duty to discuss anticipatory treatment decisions together with the patient, 
could improve doctor-patient discussions on treatment preferences and ease 
physicians’ doubts about the authenticity of ADs.
In Germany, physicians demonstrated a strong sense of duty to respect 
patient wishes and to comply with the law on ADs. The almost unconditional 
acceptance of ADs can be explained by the clear position of the law on ADs, and 
by the dual process promoted by the official AD-forms that take into account 
wishes regarding precise situations as well as general believes and values. The 
law hardly focuses on conditions that determine the validity of ADs, other 
than the requirement that the AD must comprise reflection about concrete 
situations as well as general values and beliefs.41 Although the law requires the 
38   Supra note 10.
39   Supra note 12.
40   General Medical Council, Treatment and care towards the end of life: good practices in deci-
sion making (London: General Medical Council, 2010).
41   Bundesministerium der Justiz und für Verbraucherschutz, Patientenverfügung. Leiden, — 
Krankheit — Sterben: Wie bestimme ich, was medizinisch unternommen werden soll, wenn 
ich entscheidungsunfähig bin? (BMJV.de, 2016).
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physician to establish the presumed patient wishes through discussion with 
the surrogate and/or family, it does not explicitly require the physician to have 
those discussions with the patient. Indeed, although most German physicians 
agreed on the importance of open discussions, in practice, they acknowledge 
that they do not always initiate such discussions. Consequently, many physi-
cians do not know whether a patient has written or thought about an AD.42 
Considering the German physicians’ adherence to law, a legal requirement to 
routinely discuss ADs with patients could improve also here the implementa-
tion of these documents.
In France, physicians seemed to believe that patients want to only know 
as much as they ask for, and that bad news does not always have to be shared 
with the patient.43 In such a context, ADs have long been considered as ‘foreign 
concepts’44 and were largely ignored in the clinical setting and by the media. 
A study conducted among elderly persons in France has shown that 90% of the 
participants have never heard of ADs; and even after having been informed, 
83% did not wish to write an AD, partly because they believed that physicians 
would do what they want and ADs would have no impact on their care.45 Yet, 
the debate and attitudes in France is changing. My observations have shown 
that junior doctors often value honest information but lack role models and 
communication skills training. Having laws and regulations they can refer to 
when trying to implement more patient-centred care and decision-making 
appeared to be of benefit. The above-mentioned impact of the previous law of 
2005 on public discourse and physicians’ perceptions suggest a positive effect, 
also of the new law of 2016 confirming the binding value of ADs. In view of 
its ambiguity regarding the interpretation of ADs and its remaining focus on 
medical decisions, the law will, however, not resolve French physicians’ diffi-
culty in discussing patients’ preferences at the end of life; a revision of the law 
should consider explicit emphasis on physicians’ obligations to discuss treat-
ment preferences with patients.
The data from the three countries suggests that open communication about 
patients’ treatment preferences is essential in order to respect patients’ wishes 
and that this communication needs to be improved. Such improvement could 
42   N. Evans, C. Bausewein, A. Meñaca, E.V.W. Andrew, I.J. Higginson, R. Harding, R. Pool and 
M. Gysels, ‘A critical review of advance directives in Germany: Attitudes, use and health-
care professionals’ compliance’, Patient Education and Counseling 87(3) (2012) 277-288.
43   S. Fainzang, La Relation médecins/malades: information et mensonge (Paris: PUF, 2006).
44   Supra note 11.
45   V. Fournier, D. Berthiau, E. Kempf and J. d’Haussy, ‘Quelle utilité des directives anticipées 
pour les médecins?’, Presse Médicale 42 (2013) 159-169.
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be achieved by introducing legislation that requires physicians to encourage 
discussion. A useful model for a ‘communications approach’ is Advance Care 
Planning (ACP), a process
whereby a patient, in consultation with health care providers, family 
members and important others, makes decisions about his or her future 
health care, should he or she become incapable of participating in medi-
cal treatment decisions.46
A number of studies have shown the positive impact of ACPs on the imple-
mentation of ADs.47
5 Conclusion
In all three countries, legislation concerning ADs reflects relevant societal 
debates and national contexts. This comparative study shows how the cultural 
context and the way the law is formulated impacts on physicians’ attitudes 
with regard to the implementation of ADs. The lack of communication about 
anticipatory treatment decisions and patients’ values appears to be the main 
factor hindering the implementation of ADs in practice. Depending on the 
country, various factors lead to these communication problems, such as: 
the lack of public awareness of ADs, the lack of a patient-centred approach, 
lack of clarity of the law, and the lack of specific communication skills training. 
This study shows the influence of the law on physicians’ attitudes, in contrast 
to White and Willmott.48 Although ADs are legally binding in England, France 
and Germany, there is no legal requirement to discuss ADs with patients in 
any of these jurisdictions. The introduction/revision of professional guide-
lines regarding management and implementation of ADs in each country 
may encourage these discussions and have a positive impact on the uptake of 
those directives by patients. In view of the influence of the law on physicians’ 
attitudes, a legal requirement to discuss treatment preferences is likely to per-
suade more physicians to develop care plans together with their patients. 
46   P.A. Singer, G. Robertson and D.J. Roy, ‘Bioethics for clinicians: 6. Advance care planning’, 
Canadian Medical Association Journal 155 (1996) 1689-1692.
47   C.P. Sabatino, ‘The evolution of health care advance planning law and policy’, Milbank 
Quarterly 88(2) (2010) 211-239; A. Mullick, J. Martin and L. Sallnow, ‘An introduction to 
advance care planning in practice’, British Medical Journal 347 (2013) f6064.
48   Supra note 10.
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In the same way, laws that clearly state the value of ADs without defining lim-
iting conditions under which these documents can be invalidated can allow 
physicians to overcome their hesitation to implement ADs. Tighter laws com-
bined with a legal requirement to engage in discussion and the provision of 
communication skill training will allow for increased respect of patient wishes 
and preferences based on joint reflection between physicians and patients.
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